Citrobacter-induced colitis in mice with murine acquired immunodeficiency syndrome

Veterinary Pathology

Volumn 47, Issue 2, 2010, Pages 312-317

  Fredrickson, T N ^a   Hartley, J W ^a   Morse III, H C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Citrobacter; Colitis; Murine acquired immunodeficiency syndrome

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; C57BL MOUSE; CITROBACTER RODENTIUM; COLITIS; CYTOCHEMISTRY; ENTEROBACTERIACEAE INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOUSE; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; VIROLOGY;

ANIMALS; CITROBACTER RODENTIUM; COLITIS; ENTEROBACTERIACEAE INFECTIONS; HISTOCYTOCHEMISTRY; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME;

BACTERIA (MICROORGANISMS); CITROBACTER; CITROBACTER RODENTIUM; MURINAE; MUS;

EID: 77953984742     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985809358605     Document Type: Article

References (32)

1. Barthold SW: The microbiology of transmissible murine colonic hyperplasia. Lab Anim Sci 30:167-173, 1980.
2. Barthold SW, Adams RL: Citrobacter freundii. In: Manual of Microbiologic Monitoring of Laboratory Animals, ed. Allan AM, Nomura T [Publication No. 86-2498:IL.B.1-4]. National Institutes of Health, Washington, DC, 1986.
3. Barthold SW, Coleman GL, Bhatt PN, Osbaldiston GW, Jonas AM: The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci 26:889-894, 1976.
4. Barthold SW, Osbaldiston GW, Jonas AM: Dietary, bacterial and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci 27:938-945, 1977.
5. Borenshtein D., Nambiar PR, Groff EB, Fox, JG, Schauer DB: Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun 75:3271-3281, 2007.
6. Bry L., Brenner MB: Critical role of T-cell dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172:433-441, 2004.
7. Buller RM, Yetter RA, Fredrickson TN, Morse HC III: Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol 61:383-387, 1987.
8. Curtis MM, Way SS: Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177-185, 2009.
9. Darban H., Enriquez J., Sterling CR, Lopez MC, Chen G., Abbaszadegan M., Watson RR: Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5. J Infect Dis 164:741-745, 1991.
10. Doherty TM, Giese N., Morse HC III, Coffman RL: Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania major. J Virol 71:3702-3709, 1997.
11. Doherty TM, Morse HC III, Coffman RL: Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses. Int Immunol 7:131- 138, 1995.
12. Gazzinelli RT, Hartley JW, Fredrickson TN, Chattopadhyay SK, Sher A., Morse HC III: Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses. Infect Immun 60:4394-4401, 1992.
13. Gibson DL, Ma C., Bergstrom KSB, Huang JT, Man C., Vallance, BA: MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 10:618-631, 2008.
14. Hartley JW, Fredrickson TN, Yetter RA, Makino M., Morse HC III: Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J Virol 63:1223-1231, 1989.
15. Holcombe H., Schauer DB: Enterobacteriaceae Pseudomonas aeruginosa and Streptobacillus moniliformis, III. Citrobacter rodentium. In: Diseases: The Mouse in Biomedical Research, ed. Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, vol. 2, 2nd ed., pp. 373-377. Elsevier Inc, New York, NY, 2007.
16. Hügin AW, Cerny A., Morse HC III: Mice with an acquired immunodeficiency (MAIDS) develop a persistent infection after injection with Listeria monocytogenes. Cell Immunol 155:246-252, 1994.
17. Koch S., Muralidhar G., Swain SL: Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J Immunol 152:5548-5556, 1994.
18. Lu L-F., Rudensky A.: Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 23:1270-1282, 2009.
19. Luperchio SA, Schauer DB: Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3:333-340, 2001.
20. Morawetz RA, Doherty TM, Giese NA, Hartley JW, Müller W., Kühn R., Rajewsky K., Coffman R., Morse HC III: Resistance to murine acquired immunodeficiency syndrome (MAIDS). Science 265:264-266, 1994.
21. Morse HC III, Chattopadhyay SK, Makino M., Fredrickson TN, Hügin AW, Hartley JW: Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607-621, 1992.
22. Morse HC III, Giese N., Morawetz R., Tang Y., Gazzinelli R., Kim WK, Chattopadhyay S., Hartley JW: Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice. Springer Semin Immunopathol 17:2312-2345, 1995.
23. Mundy R., MacDonald TT, Dougan G., Frankel G., Wiles S.: Citrobacter rodentium of mice and man. Cell Microbiol 7:1697-1706, 2005.
24. Peacock CD, Olver SD, Price P.: Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis. Am J Pathol 150:1089-1100, 1997.
25. Schauer DB, Zabel BA, Pedraza IF, O'Hara CM, Steigerwalt AG, Brenner DJ: Genetic and biochemical characterization of Citrobacter rodentium sp nov. J Clin Microbiol 33:2064-2068, 1995.
26. Silverman J., Chavannes J-M., Rigotty J., Ornaf M.: A natural outbreak of transmissible murine colonic hyperplasia in A/J mice. Lab Anim Sci 29:209-213, 1979.
27. Suzuki K., Narita T., Yui R., Ohtsuka K., Inada S., Kimura T., Okada Y., Makino M., Mizuochi T., Asakura H., Fujiwara M.: Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus. Gut 41:221-228, 1997.
28. Torchinsky MB, Garaude J., Martin AP, Blander JM: Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation. Nature 458:78-82, 2009.
29. Umar S., Wang Y., Morris AP, Sellin JH: Dual alterations in casein kinase I-ε and GSK-3β modulate β-catenin stability in hyperproliferating colonic epithelia. Am J Physiol Gastrointest Liver Physiol 292:G599-G607, 2007.
30. Vallance BA, Deng W., Jacobson K., Finlay BB: Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71:3443-3453, 2003.
31. Veltkamp C., Ruhwald R., Giesem T., Autschbach F., Kaden I., Veltkamp R., Sartor B., Stremmel W.: CD4+CD25+ cell depletion from the normal CD4+ T cell pool prevents tolerance toward the intestinal flora and leads to chronic colitis in immunodeficient mice. Inflamm Bowel Dis 12:437-446, 2006.
32. Wang Y., Xiang GS, Kourouma F., Umar S.: Citrobacter rodentium-induced NF-κB activation in hyperproliferating colonic epithelia: role of p65 (Ser 536) phosphorylation. Br J Pharmacol 148:814-824, 2006.